Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock
Sponsor: Children's Hospital of Fudan University
Summary
Severe sepsis and septic shock remain the leading causes of child mortality worldwide. Sepsis is a complex process that ultimately leads to circulation disorders, organ perfusion abnormalities, capillary leakage, tissue hypoxia, and organ failure. The difficulty of clinical treatment is microcirculation and mitochondrial dysfunction in septic shock. Once shock enters the stage of microcirculation failure, conventional treatment is ineffective. ECMO can effectively support the circulatory system and provide good oxygen delivery, but there are many controversies in clinical treatment. 1) whether ECMO can effectively improve the clinical prognosis of children with septic shock; 2) appropriate timing for ECMO intervention; 3) which key clinical factors affect the effect of ECMO treatment. This study intends to adopt a multi-center, prospective, non-randomized controlled trial design, and the main research hypothesis is whether ECMO treatment can improve the success of discharge survival of children with septic shock.
Official title: Study on the Efficacy and Timing of Extracorporeal Membrane Oxygenation (ECMO) Therapy in Children With Refractory Septic
Key Details
Gender
All
Age Range
29 Days - 18 Years
Study Type
OBSERVATIONAL
Enrollment
60
Start Date
2020-08-01
Completion Date
2026-12-31
Last Updated
2026-03-16
Healthy Volunteers
No
Interventions
ECMO
ECMO is used to intervene septic shock and refractory septic shock
Locations (1)
Children'S Hosptial of Fuan University
Shanghai, China